Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA Sees Benefits, Risks in Antipsychotics for Children
FDA Sees Benefits, Risks in Antipsychotics for Children
FDA Sees Benefits, Risks in Antipsychotics for Children
Submitted by
admin
on June 6, 2009 - 10:10am
Source:
Wall Street Journal
News Tags:
Seroquel
Geodon
Zyprexa
AstraZeneca
Eli Lilly
Pfizer
Headline:
FDA Sees Benefits, Risks in Antipsychotics for Children
Do Not Allow Advertisers to Use My Personal information
